EXK:NYSEEndeavour Silver Corporation Analysis
Data as of 2026-07-01 - not real-time
$8.28
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Endeavour Silver (EXK) is trading at $8.28, with the 20‑day SMA (≈8.46) sitting below both the 50‑day (≈9.21) and 200‑day (≈9.51) averages, signaling a short‑term bearish bias, yet the MACD line is marginally above its signal, hinting at a possible early reversal. RSI sits at 45, indicating neutral momentum, while price hovers just above the computed support of $7.36 and well under the resistance near $9.94, leaving limited upside in the near term. Volatility is extremely high at over 76% for the past 30 days and beta exceeds 2.5, underscoring pronounced price swings and market sensitivity. Despite these technical headwinds, the fundamentals are robust: operating margin is a strong 39.9%, gross margin 40.4%, and the latest quarter showed a 78% jump in silver production to 3 million ounces, with operating cash flow surging 400% to $115 million. Forward EPS of $1.32 translates to a forward P/E of just 6.3, and analysts (3) collectively rate the stock as a strong buy with a median target of $16, implying sizable upside. However, the balance sheet is tight—total debt of $251 million yields a debt‑to‑equity ratio near 39, and the company posted a negative profit margin of -3.5%, so the upside is contingent on sustaining cash flow and managing leverage.
Given the blend of high‑beta technical weakness, exceptional operating performance, and a market consensus that the stock is undervalued relative to its growth trajectory, investors should view EXK as a medium‑ to long‑term opportunity while remaining cautious of short‑term volatility and debt‑related risks.
Given the blend of high‑beta technical weakness, exceptional operating performance, and a market consensus that the stock is undervalued relative to its growth trajectory, investors should view EXK as a medium‑ to long‑term opportunity while remaining cautious of short‑term volatility and debt‑related risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with decreasing volume
- High 30‑day volatility and beta >2.5
- Neutral momentum (RSI 45) and modest bullish MACD signal
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 78% increase in silver production and 400% jump in operating cash flow
- Forward EPS $1.32 and forward P/E 6.3 indicating cheap valuation
- Analyst consensus strong‑buy with median target $16
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained high operating margins (~40%) despite negative net profit
- Strategic assets in Mexico, Chile, Peru and US reducing geographic concentration
- Low forward P/E and strong cash generation to deleverage balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth230.20%
Profit Margin-3.47%
P/E Ratio6.3
ROE-3.88%
ROA7.42%
Debt/Equity38.98
P/B Ratio3.8
Op. Cash Flow$84.7M
Free Cash Flow$14.1M
Technical Analysis
TrendBearish
RSI45.0
Support$7.36
Resistance$9.94
MA 20$8.46
MA 50$9.21
MA 200$9.51
MACDBullish
VolumeDecreasing
Fear & Greed Index92.05
Valuation
Fair Value$1.71
Target Price$16.17
Upside/Downside95.25%
GradeFair
TypeBlend
Risk Assessment
Beta2.68
Volatility76.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.